Guidance

NWAFT Departmental Advice for Common Haematological Abnormalities

This guidance has been written by the NWAFT Haematology team to support primary care. Click on the link below to download the guidance!

The guidance is useful to consider how to investigate haematological abnormal results but, as an LMC, we do not advise practices to undertake some suggestions in the guidance like non-comissioned monitoring of things such as MGUS and CLL.

NWAFT Haematology GP FAQs V1 January 2022 CE 2024!

First Published
30 May 2025
Updated On
18 June 2025
Due to be Reviewed
30 November 2025
Not signed in.

Please Login or Register an account to access the ability to favourite this.
Share this article

You might also find this useful...

Expansion of Shingles Vaccination
Expansion of Shingles Vaccination
31 July 2025
A letter has been published detailing the planned expansion of the Shingles vaccination programme to include all those who are severely immunosuppressed and aged 18-49 years old from 1 September…
Cont. Reading
OpenSAFELY Expansion – Action Required
OpenSAFELY Expansion – Action Required
30 July 2025
The Data Provision Notice (DPN) for OpenSAFELY now permits expansion beyond COVID-19-related analyses. The opt-in functionality for EMIS was rolled out this week.  SystmOne already has this functionality in place.…
Cont. Reading
MMR vaccinations for practice staff 
MMR vaccinations for practice staff 
26 July 2025
Due to the recent measles outbreaks, GP practices are permitted to administer MMR vaccines to their eligible staff who are registered with another practice under INT (immediately necessary treatment).  This…
Cont. Reading